|
Q2 FY2015
As of Jan 31, 2015
|
Q1 FY2015
As of Oct 31, 2014
|
Q4 FY2014
As of Jul 31, 2014
|
Q3 FY2014
As of Apr 30, 2014
|
Q2 FY2014
As of Jan 31, 2014
|
Q1 FY2014
As of Oct 31, 2013
|
Q4 FY2013
As of Jul 31, 2013
|
Q3 FY2013
As of Apr 30, 2013
|
Q2 FY2013
As of Jan 31, 2013
|
Q1 FY2013
As of Oct 31, 2012
|
Q4 FY2012
As of Jul 31, 2012
|
Q3 FY2012
As of Apr 30, 2012
|
Q2 FY2012
As of Jan 31, 2012
|
Q1 FY2012
As of Oct 31, 2011
|
Q4 FY2011
As of Jul 31, 2011
|
Q3 FY2011
As of Apr 30, 2011
|
Q2 FY2011
As of Jan 31, 2011
|
Q1 FY2011
As of Oct 31, 2010
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current assets | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Accounts receivable, less allowances of $410 and $333, respectively | ||||||||||||||||||
| Inventory | ||||||||||||||||||
| Deferred costs of revenue | ||||||||||||||||||
| Prepaids and other current assets | ||||||||||||||||||
| Deferred income tax assets, current | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Deferred income tax assets, non-current | ||||||||||||||||||
| Other non-current assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Current liabilities | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Income taxes payable, current | ||||||||||||||||||
| Deferred income tax liability | ||||||||||||||||||
| Deferred revenue, current | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Deferred income tax liability, non-current | ||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||
| Common stock: $0.0001 par value; 350,000 shares authorized; 107,289 and 107,557 shares issued and outstanding, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||
Loading...
